评论 12
过滤器:
评分
语言
种类:
最近的
A
9 几个月前

👏 Vaxxas has exceeded my expectations with their v...

👏 Vaxxas has exceeded my expectations with their vaccines. The level of protection and the ease of administration are outstanding. I can confidently say that Vaxxas is a leader in the vaccine industry.

1
9 几个月前

I recently tried Vaxxas vaccines and was impressed...

I recently tried Vaxxas vaccines and was impressed by their effectiveness and safety. The company's commitment to quality and innovation is truly commendable. I would recommend Vaxxas without hesitation.

J
10 几个月前

Vaxxas has been a game-changer in the vaccine indu...

Vaxxas has been a game-changer in the vaccine industry. Their innovative approach to vaccine delivery has greatly improved the efficacy and convenience of immunization. I have nothing but positive things to say about Vaxxas and their products.

K
11 几个月前

The vaccines from Vaxxas are simply amazing! 😊 I c...

The vaccines from Vaxxas are simply amazing! 😊 I couldn't be happier with the protection they provide and the convenience they offer. I highly recommend Vaxxas to everyone in need of reliable vaccines.

J
11 几个月前

As a customer, I am very impressed with the compan...

As a customer, I am very impressed with the company's offerings. The vaccines provided by Vaxxas are of great quality and have proven to be effective. I appreciate their commitment to delivering safe and reliable vaccines to the market.

W
1年以前

The experience I had with Vaxxas was truly remarka...

The experience I had with Vaxxas was truly remarkable. Their vaccines are unparalleled in terms of efficacy and safety. I'm grateful for their commitment to public health and would highly recommend their products.

A
1年以前

I am incredibly impressed with Vaxxas and their in...

I am incredibly impressed with Vaxxas and their innovative vaccine delivery system. Their products are effective and reliable, making immunization a breeze. I highly recommend Vaxxas for anyone looking for top-quality vaccines.

M
1年以前

I recently tried Vaxxas vaccines and was pleasantl...

I recently tried Vaxxas vaccines and was pleasantly surprised by their effectiveness. The whole process was seamless, and I appreciate the company's dedication to providing high-quality vaccines. I would definitely recommend them to others.

V
1年以前

👍 The products from Vaxxas are amazing! I'm extrem...

👍 The products from Vaxxas are amazing! I'm extremely satisfied with their vaccines and the level of protection they provide. I feel confident in recommending Vaxxas to others who are looking for top-quality vaccines.

R
1年以前

Vaxxas has set a new standard in the vaccine indus...

Vaxxas has set a new standard in the vaccine industry. Their vaccines are highly effective and their delivery system is revolutionary. I can confidently say that Vaxxas is the best choice for reliable and safe immunization.

C
1年以前

I must say that the experience I had with Vaxxas w...

I must say that the experience I had with Vaxxas was nothing short of excellent. The quality of their products is top-notch, and the service provided by their team was outstanding. I highly recommend Vaxxas to anyone in need of reliable vaccines.

关于Vaxxas

Vaxxas:用无针技术革新疫苗接种

疫苗是人类历史上最重大的医学突破之一,挽救了数百万人的生命并预防了无数疾病。然而,使用针头和注射器的传统疫苗接种方法有一些限制,阻碍了它们的有效性和可及性。这就是 Vaxxas 的用武之地——一家开创性公司,正在通过其创新的无针技术改变我们接种疫苗的方式。

Vaxxas 由昆士兰大学的 Mark Kendall 教授于 2011 年创立,开发了一个名为 Nanopatch 的突破性平台,该平台通过贴在皮肤上的小贴片上的数千个微小突起来输送疫苗。这种方法与传统注射相比有几个优点,包括提高免疫反应、减少疫苗剂量、简化管理和减少浪费。

Vaxxas 的使命是将这项技术商业化,并使其广泛应用于世界各地的人们。该公司已经与默克公司等领先的制药公司合作,使用 Nanopatch 技术开发针对流感、HPV(人乳头瘤病毒)、COVID-19(冠状病毒)等各种疾病的新疫苗。

Nanopatch 的主要优势之一是它能够通过直接靶向皮肤表面下的免疫细胞来增强疫苗效力。与依赖肌肉组织吸收的传统注射不同,Nanopatch 可以将疫苗直接输送到树突状细胞——负责启动针对病原体的免疫反应的专门免疫细胞。与传统方法相比,这种有针对性的方法可以产生更快、更强的免疫力。

Nanopatch 的另一个优势是它能够显着减少疫苗剂量,同时保持甚至提高功效。由于输送机制效率低下或在储存或运输过程中发生降解,传统注射剂通常需要更高的剂量。凭借 Nanopatch 精确的输送系统和稳定的配方,更低的剂量可以获得更好的效果,同时降低成本和浪费。

此外,Nanopatch 还具有多项实用优势,使其成为大规模疫苗接种活动的理想选择,尤其是在资源有限的环境中。该贴剂易于应用,不需要专门培训或设备,适合社区卫生工作者等非医务人员使用。它还消除了针刺伤和污染的风险,减少了锐器处理和感染控制措施的需要。

Vaxxas 通过严格的临床前和临床研究在推进 Nanopatch 技术方面取得了重大进展。该公司已在多种动物模型中证明了其安全性和有效性,包括小鼠、大鼠、兔子、猪和非人类灵长类动物。它还进行了几项人体试验,这些试验在免疫反应和耐受性方面显示出可喜的结果。

除了核心技术平台外,Vaxxas 还在开发一系列利用 Nanopatch 独特功能的产品。其中包括针对流感、HPV(人乳头瘤病毒)、COVID-19(冠状病毒)、疟疾、登革热等传染病的疫苗;以及用于癌症免疫治疗的治疗性疫苗。

Vaxxas 创新的疫苗接种方法获得了科学界和行业专家的广泛认可。公司获得了比尔及梅琳达·盖茨基金会、美国国立卫生研究院 (NIH)、澳大利亚研究委员会 (ARC)、昆士兰州政府等组织颁发的众多奖项和资助;除其他外。

随着 Vaxxas 继续推进其技术平台并通过在全球范围内建立新的合作伙伴关系扩大其产品线——它准备通过更安全、更有效的替代方案彻底改变疫苗接种领域,从而改变全球数百万人的生活。

综上所述:

Vaxxas 是一家开创性公司,旨在将使用针头的传统疫苗接种方法转变为一种名为 Nanopatch 的创新无针技术。与传统注射相比,这种方法具有多项优势,包括提高免疫反应、减少疫苗剂量、简化给药、减少浪费等,这使其成为大规模疫苗接种活动的理想选择,尤其是在资源有限的环境中。 Vaxxas 通过严格的临床前和临床研究在推进 Nanopatch 技术方面取得了重大进展,它准备通过更安全、更有效的替代方案彻底改变疫苗接种领域,从而改变全球数百万人的生活。

已翻译